These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15900322)

  • 1. Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groups.
    Banerjee AL; Tobwala S; Haldar MK; Swanson M; Roy BC; Mallik S; Srivastava DK
    Chem Commun (Camb); 2005 May; (20):2549-51. PubMed ID: 15900322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
    Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic inactivation of human carbonic anhydrase I by a metallopeptide-sulfonamide conjugate is mediated by oxidation of active site residues.
    Gokhale NH; Bradford S; Cowan JA
    J Am Chem Soc; 2008 Feb; 130(8):2388-9. PubMed ID: 18251475
    [No Abstract]   [Full Text] [Related]  

  • 5. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors.
    Puerta DT; Cohen SM
    Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction.
    Saragusti AC; Ortega MG; Cabrera JL; Estrin DA; Marti MA; Chiabrando GA
    Eur J Pharmacol; 2010 Oct; 644(1-3):138-45. PubMed ID: 20619256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of an organometallic glutathione transferase inhibitor.
    Ang WH; Parker LJ; De Luca A; Juillerat-Jeanneret L; Morton CJ; Lo Bello M; Parker MW; Dyson PJ
    Angew Chem Int Ed Engl; 2009; 48(21):3854-7. PubMed ID: 19396894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
    Nuti E; Orlandini E; Nencetti S; Rossello A; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2007 Mar; 15(6):2298-311. PubMed ID: 17276072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
    Li Q; Fang H; Xu W
    Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures, spectra, and DNA-binding properties of mixed ligand copper(II) complexes of iminodiacetic acid: the novel role of diimine co-ligands on DNA conformation and hydrolytic and oxidative double strand DNA cleavage.
    Selvakumar B; Rajendiran V; Uma Maheswari P; Stoeckli-Evans H; Palaniandavar M
    J Inorg Biochem; 2006 Mar; 100(3):316-30. PubMed ID: 16406550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.
    Lee M; Bernardo MM; Meroueh SO; Brown S; Fridman R; Mobashery S
    Org Lett; 2005 Sep; 7(20):4463-5. PubMed ID: 16178559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design in silico, synthesis and binding evaluation of a carbohydrate-based scaffold for structurally novel inhibitors of matrix metalloproteinases.
    Fragai M; Nativi C; Richichi B; Venturi C
    Chembiochem; 2005 Aug; 6(8):1345-9. PubMed ID: 15977273
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of inhibition of purified bovine neutrophil matrix metalloproteinase 9 by low-molecular-weight inhibitors.
    Bannikov GA; Lakritz J; Premanandan C; Mattoon JS; Abrahamsen EJ
    Am J Vet Res; 2009 May; 70(5):633-9. PubMed ID: 19405903
    [TBL] [